Finally, our findings showed that AMPK activation with metformin blocked the effects of JMJD1C hyperexpression, whereas AMPK knockdown blockaded the effects of JMJD1C downregulation during cardiac hypertrophy. Here, JMJD1C is linked to cardiac hypertrophy.